Development & Verification
Contestability & redress
Data & digital tools:
The principle of Contestability & Redress may not currently apply during Development & Verification for digital predictive tools in chemistry manufacturing and controls. However, as AI and other technologies are developing at rapid rate, this may change in future. Please consult the references for this section for more information.
Personnel Training:
Currently, training related to Contestability & Redress may not be necessary during Development & Verification for digital predictive tools in chemistry manufacturing and controls. However, as AI and other technologies are developing at rapid rate, this may change in future. Please consult the references for this section for more information.
Links:
ICH Q8(R2): https://database.ich.org/sites/default/files/Q8%28R2%29%20Guideline.pdf
ICH Q9(R1): https://database.ich.org/sites/default/files/ICH_Q9%28R1%29_Guideline_Step4_2025_0115_0.pdf
ICH Q10: https://database.ich.org/sites/default/files/Q10%20Guideline.pdf
ICH Q13: https://database.ich.org/sites/default/files/ICH_Q13_Step4_Guideline_2022_1116.pdf
ISO/IEC 23894:2023 (Information technology — Artificial intelligence — Guidance on risk management): https://www.iso.org/standard/77304.html
ISO/IEC 27001:2022/Amd 1:2024 (Information security, cybersecurity and privacy protection — Information security management systems — Requirements): https://www.iso.org/standard/88435.html
ISO/IEC 27002:2022 (Information security, cybersecurity and privacy protection — Information security controls): https://www.iso.org/standard/75652.html
ISO 42001:2023 (Information technology — Artificial intelligence — Management system): https://www.iso.org/standard/42001
ISPE GAMP Guide: Artificial Intelligence: https://ispe.org/publications/guidance-documents/gamp-guide-artificial-intelligence?utm_source=HubSpot&utm_medium=Popup&utm_campaign=Guide%20GAMP%20AI&hsCtaAttrib=192776150296
FDA Good Machine Learning Practice for Medical Device Development: Guiding Principles: https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles
EMA and FDA set common principles for AI in medicine development: https://www.ema.europa.eu/en/news/ema-fda-set-common-principles-ai-medicine-development-0
EMA Reflection Paper on the use of Artificial Intelligence (AI) in the medicinal product lifecycle: https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-use-artificial-intelligence-ai-medicinal-product-lifecycle_en.pdf
EMA Artificial Intelligence: https://www.ema.europa.eu/en/about-us/how-we-work/data-regulation-big-data-other-sources/artificial-intelligence
EMA Artificial intelligence workplan to guide use of AI in medicines regulation: https://www.ema.europa.eu/en/news/artificial-intelligence-workplan-guide-use-ai-medicines-regulation
EU AI Act Article 9: Risk Management System: https://artificialintelligenceact.eu/article/9
EU AI Act Article 12: Record-Keeping: https://www.euaiact.com/article/12
Artificial Intelligence Playbook for the UK Government: https://www.gov.uk/government/publications/ai-playbook-for-the-uk-government/artificial-intelligence-playbook-for-the-uk-government-html
UK Government A pro-innovation approach to AI regulation: https://www.gov.uk/government/publications/ai-regulation-a-pro-innovation-approach/white-paper